← FDA Drug Approvals (Drugs@FDA)

OLANZAPINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CADILA PHARMS LTD · Approved 2023-02-24

Drug application

FDA Application #

ANDA210022

Application type

Abbreviated New Drug Application (Generic)

Brand name

OLANZAPINE

Generic name

OLANZAPINE

Active ingredients

OLANZAPINE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

CADILA PHARMS LTD

Manufacturer

Modavar Pharmaceuticals LLC

First approval

2023-02-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown